EUVIMEDEUVIMED entdecken
Crossref

Review of TOGOBM study

Rajesh Jain

Diabetes Asia Journal · 2024

DOI: 10.62996/daj.30112024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Asia Journal, 2024. Verfasst von Rajesh Jain.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this TOBGM study, Intervention started very late, with OGTT performed an average of 15.6 weeks. And this is why it results in a modest reduction in primary outcome in the immediate treatment arm (24.9% Vs. Control group (30.5%), adjusted risk reduction 5.6%. OGTT was performed in less than 14 weeks in 23.2% of Women only, and most of the women were beyond the 14th week at entry level in both the Intervention and control groups. Insulin and Metformin use was more in the Treatment arm than in the control arm, 58.1% vs. 41.4% and 23.6% Vs. 10.4%, respectively. Interestingly, more benefits were seen in less than the 14th week of pregnancy.

Zitieren

APA

Jain, R. (2024). Review of TOGOBM study. Diabetes Asia Journal. https://doi.org/10.62996/daj.30112024

Vancouver

Jain R. Review of TOGOBM study. Diabetes Asia Journal. 2024. doi:10.62996/daj.30112024

BibTeX
@article{Jain2024,
  author = {Jain, Rajesh},
  title = {Review of TOGOBM study},
  journal = {Diabetes Asia Journal},
  year = {2024},
  doi = {10.62996/daj.30112024}
}
Kostenlos starten →